These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8118795)
1. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer. Vachtenheim J; Horáková I; Novotná H Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795 [TBL] [Abstract][Full Text] [Related]
2. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529 [TBL] [Abstract][Full Text] [Related]
3. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. D'Amico D; Carbone DP; Johnson BE; Meltzer SJ; Minna JD Cancer Res; 1992 Apr; 52(7):1996-9. PubMed ID: 1348017 [TBL] [Abstract][Full Text] [Related]
4. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
5. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers. Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342 [TBL] [Abstract][Full Text] [Related]
6. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer]. Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692 [TBL] [Abstract][Full Text] [Related]
7. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Ryberg D; Kure E; Lystad S; Skaug V; Stangeland L; Mercy I; Børresen AL; Haugen A Cancer Res; 1994 Mar; 54(6):1551-5. PubMed ID: 8137262 [TBL] [Abstract][Full Text] [Related]
8. K-ras activation in non-small cell lung cancer in the dog. Kraegel SA; Gumerlock PH; Dungworth DL; Oreffo VI; Madewell BR Cancer Res; 1992 Sep; 52(17):4724-7. PubMed ID: 1324792 [TBL] [Abstract][Full Text] [Related]
9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
10. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591 [TBL] [Abstract][Full Text] [Related]
11. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602 [TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Mills NE; Fishman CL; Rom WN; Dubin N; Jacobson DR Cancer Res; 1995 Apr; 55(7):1444-7. PubMed ID: 7882350 [TBL] [Abstract][Full Text] [Related]
13. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma. Ogata N; Kamimura T; Asakura H Hepatology; 1991 Jan; 13(1):31-7. PubMed ID: 1846346 [TBL] [Abstract][Full Text] [Related]
14. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. Sugimura H; Caporaso NE; Modali RV; Hoover RN; Resau JH; Trump BF; Longergan JA; Krontiris TG; Mann DL; Weston A Cancer Res; 1990 Mar; 50(6):1857-62. PubMed ID: 2407346 [TBL] [Abstract][Full Text] [Related]
15. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Mitsudomi T; Steinberg SM; Oie HK; Mulshine JL; Phelps R; Viallet J; Pass H; Minna JD; Gazdar AF Cancer Res; 1991 Sep; 51(18):4999-5002. PubMed ID: 1654209 [TBL] [Abstract][Full Text] [Related]
16. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients. Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881 [TBL] [Abstract][Full Text] [Related]
20. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Sugio K; Kishimoto Y; Virmani AK; Hung JY; Gazdar AF Cancer Res; 1994 Nov; 54(22):5811-5. PubMed ID: 7954406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]